Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

589 ARTÍCULOS , VIENDO DEL 421 AL 435

MicroRNAs in Alzheimer's disease: Potential diagnostic markers and therapeutic targets

Liu S, Fan M, Zheng Q, Hao S, Yang L, Xia Q, Qi C, Ge J.

Biomed Pharmacother. 2022 Apr;148:112681. doi: 10.1016/j.biopha.2022.112681. Epub 2022 Feb 15.

Addressing the disparities in dementia risk, early detection and care in Latino populations: Highlights from the second Latinos & Alzheimer's Symposium

Quiroz YT, Solis M, Aranda MP, Arbaje AI, Arroyo-Miranda M, Cabrera LY, Carrasquillo MM, Corrada MM, Crivelli L, Diminich ED, Dorsman KA, Gonzales M, González HM, Gonzalez-Seda AL, Grinberg LT, Guerrero LR, Hill CV, Jimenez-Velazquez IZ, Guerra JJL, Lopera F, Maestre G, Medina LD, O'Bryant S, Peñaloza C, Pinzon MM, Mavarez RVP, Pluim CF, Raman R, Rascovsky K, Rentz DM, Reyes Y, Rosselli M, Tansey MG, Vila-Castelar C, Zuelsdorff M, Carrillo M, Sexton C.

Alzheimers Dement. 2022 Sep;18(9):1677-1686. doi: 10.1002/alz.12589. Epub 2022 Feb 24.

Advances in aptamers against Aβ and applications in Aβ detection and regulation for Alzheimer's disease

Zheng Y, Zhang L, Zhao J, Li L, Wang M, Gao P, Wang Q, Zhang X, Wang W.

Theranostics. 2022 Jan 31;12(5):2095-2114. doi: 10.7150/thno.69465. eCollection 2022.

α-synuclein as an emerging pathophysiological biomarker of Alzheimer's disease

Beatino MF, De Luca C, Campese N, Belli E, Piccarducci R, Giampietri L, Martini C, Perugi G, Siciliano G, Ceravolo R, Vergallo A, Hampel H, Baldacci F.

Expert Rev Mol Diagn. 2022 Apr;22(4):411-425. doi: 10.1080/14737159.2022.2068952. Epub 2022 May 6.

Diabetic patients treated with metformin during early stages of Alzheimer's disease show a better integral performance: data from ADNI study

Pomilio C, Pérez NG, Calandri I, Crivelli L, Allegri R; ADNI Alzheimer’s Disease Neuroimaging Initiative; Sevlever G, Saravia F.

Geroscience. 2022 Jun;44(3):1791-1805. doi: 10.1007/s11357-022-00568-6. Epub 2022 Apr 20.

Blood-Based Biomarkers for Alzheimer's Disease Diagnosis and Progression: An Overview

Varesi A, Carrara A, Pires VG, Floris V, Pierella E, Savioli G, Prasad S, Esposito C, Ricevuti G, Chirumbolo S, Pascale A.

Cells. 2022 Apr 17;11(8):1367. doi: 10.3390/cells11081367.

Blood biomarkers for Alzheimer's disease and related disorders

Zetterberg H, Schott JM.

Acta Neurol Scand. 2022 Jul;146(1):51-55. doi: 10.1111/ane.13628. Epub 2022 Apr 25.

Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease

Budd Haeberlein S, Aisen PS, Barkhof F, Chalkias S, Chen T, Cohen S, Dent G, Hansson O, Harrison K, von Hehn C, Iwatsubo T, Mallinckrodt C, Mummery CJ, Muralidharan KK, Nestorov I, Nisenbaum L, Rajagovindan R, Skordos L, Tian Y, van Dyck CH, Vellas B, Wu S, Zhu Y, Sandrock A.

J Prev Alzheimers Dis. 2022;9(2):197-210. doi: 10.14283/jpad.2022.30.

Effects of interventions on cerebral perfusion in the Alzheimer's disease spectrum: A systematic review

Marcolini S, Frentz I, Sanchez-Catasus CA, Mondragon JD, Feltes PK, van der Hoorn A, Borra RJH, Ikram MA, Dierckx RAJO, De Deyn PP.

Ageing Res Rev. 2022 Aug;79:101661. doi: 10.1016/j.arr.2022.101661. Epub 2022 Jun 4.

New Insights into Neuroinflammation Involved in Pathogenic Mechanism of Alzheimer's Disease and Its Potential for Therapeutic Intervention

Li T, Lu L, Pember E, Li X, Zhang B, Zhu Z.

Cells. 2022 Jun 14;11(12):1925. doi: 10.3390/cells11121925.

Tau as a Biomarker of Neurodegeneration

Holper S, Watson R, Yassi N.

Int J Mol Sci. 2022 Jun 30;23(13):7307. doi: 10.3390/ijms23137307.

Insights for Alzheimer's disease pharmacotherapy and current clinical trials

Nascimento ALCS, Fernandes RP, Carvalho ACS, Frigieri I, Alves RC, Chorilli M.

Neurochem Int. 2022 Oct;159:105401. doi: 10.1016/j.neuint.2022.105401. Epub 2022 Jul 13.

Biomarkers for Alzheimer's Disease: Context of Use, Qualification, and Roadmap for Clinical Implementation

Cummings J, Kinney J.

Medicina (Kaunas). 2022 Jul 19;58(7):952. doi: 10.3390/medicina58070952.

Association between Human Blood Metabolome and the Risk of Alzheimer's Disease

Sun L, Guo D, Jia Y, Shi M, Yang P, Wang Y, Liu F, Chen GC, Zhang Y, Zhu Z.

Ann Neurol. 2022 Nov;92(5):756-767. doi: 10.1002/ana.26464. Epub 2022 Aug 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias